... measure lymphatic flow and obstruction in real time; diagnose and classify pediatric lymphatic abnormalities; detect lymphatic dysfunction; and predict an individual's risk of developing lymphedema.
... 3 SELVA study of QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), an investigational therapy under development for the treatment of microcystic lymphatic malformations (microcystic LMs).
ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional gut lymphatics and local inflammation linked to metabolic disease and pancreatic cancer.
The lymphatic network (a web of vessels, nodes and organs) helps to regulate fluid balance, transport immune cells and clear cellular waste ... “Movement is essential for lymph propulsion,” explains lymphatic specialist Flavia Morellato.
Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) in Microcystic LymphaticMalformations... About Microcystic Lymphatic Malformations.
Oral cancers with a high risk of recurrence can be identified at an early stage by examining the lymphatic vessels of the tumour ... showed a higher number of proliferating lymphatic vessels than normal.
This puts lymphatic dry brushing tools in the ranks of depuffing tools like gua shas and face rollers that stimulate the body’s natural detoxification process ... to promoting lymphatic drainage.